$TSNDF
TerrAscend Corp. Stock $tsndf

$tsndf Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000095017023021207 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$72.12M	$69.40M
YoY Change	11.3%	39.75%
Cost Of Revenue	$35.90M	$35.50M
YoY Change	-14.14%	2.84%
Gross Profit	$36.23M	$33.90M
YoY Change	57.55%	123.91%
Gross Profit Margin	50.23%	48.85%
Selling, General & Admin	$30.48M	$27.73M
YoY Change	-10.31%	22.96%
% of Gross Profit	84.13%	81.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.395M	$3.257M
YoY Change	12.16%	31.01%
% of Gross Profit	9.37%	9.61%
Operating Expenses	$32.73M	$30.09M
YoY Change	-11.54%	19.56%
Operating Profit	$3.498M	$3.806M
YoY Change	-124.98%	-137.95%
Interest Expense	-$9.310M	-$8.106M
YoY Change	-124.62%	364.53%
% of Operating Profit	-266.15%	-212.98%
Other Income/Expense, Net	-$206.0K	$24.00K
YoY Change	-31.56%	-109.76%
Pretax Income	-$6.407M	-$6.514M
YoY Change	-133.99%	-46.88%
Income Tax	$6.448M	$12.66M
% Of Pretax Income
Net Earnings	-$13.48M	-$22.77M
YoY Change	-201.96%	39.2%
Net Earnings / Revenue	-18.68%	-32.81%
Basic Earnings Per Share	-$0.05	-$0.09
Diluted Earnings Per Share	-$0.05	-$0.09
COMMON SHARES
Basic Shares Outstanding	274.7M	273.4M
Diluted Shares Outstanding	275.2M	267.2M

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.80M	$34.96M
YoY Change	-41.33%	-62.22%
Cash & Equivalents	$28.92M	$32.93M
Short-Term Investments	$1.900M	$2.026M
Other Short-Term Assets	$12.30M	$19.02M
YoY Change	48.91%	155.29%
Inventory	$54.02M	$50.81M
Prepaid Expenses
Receivables	$9.478M	$8.993M
Other Receivables	$1.100M	$1.476M
Total Short-Term Assets	$106.6M	$113.8M
YoY Change	-22.35%	-39.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$209.0M	$214.0M
YoY Change	-12.48%	1.09%
Goodwill	$99.95M	$95.71M
YoY Change	-58.46%	-59.39%
Intangibles	$269.6M	$243.8M
YoY Change	-23.33%	-31.23%
Long-Term Investments
YoY Change
Other Assets	$848.0K	$3.594M
YoY Change	-83.03%	-25.48%
Total Long-Term Assets	$615.1M	$587.8M
YoY Change	-29.4%	-30.79%
TOTAL ASSETS
Total Short-Term Assets	$106.6M	$113.8M
Total Long-Term Assets	$615.1M	$587.8M
Total Assets	$721.7M	$701.6M
YoY Change	-28.44%	-32.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.80M	$50.78M
YoY Change	-11.71%	3.19%
Accrued Expenses	$1.900M	$2.314M
YoY Change	394.79%	39.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$24.20M	$51.93M
YoY Change	-59.83%	-13.65%
Total Short-Term Liabilities	$133.5M	$156.1M
YoY Change	-4.92%	5.26%
LONG-TERM LIABILITIES
Long-Term Debt	$189.0M	$152.8M
YoY Change	1.85%	-17.37%
Other Long-Term Liabilities	$16.37M	$15.84M
YoY Change	30.92%	366.05%
Total Long-Term Liabilities	$292.7M	$246.2M
YoY Change	-9.46%	-32.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$133.5M	$156.1M
Total Long-Term Liabilities	$292.7M	$246.2M
Total Liabilities	$426.1M	$402.3M
YoY Change	-8.09%	-21.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$653.6M	-$641.5M
YoY Change	107.41%	94.48%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$293.6M	$296.6M
YoY Change
Total Liabilities & Shareholders Equity	$721.7M	$701.6M
YoY Change	-28.44%	-32.31%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$13.48M	-$22.77M
YoY Change	-201.96%	39.2%
Depreciation, Depletion And Amortization	$3.395M	$3.257M
YoY Change	12.16%	31.01%
Cash From Operating Activities	$690.0K	$8.434M
YoY Change	-104.28%	-144.75%
INVESTING ACTIVITIES
Capital Expenditures	$2.260M	$2.497M
YoY Change	-123.71%	-40.45%
Acquisitions
YoY Change
Other Investing Activities	$8.960M	-$9.070M
YoY Change	-302.67%	-149.8%
Cash From Investing Activities	$6.700M	-$11.58M
YoY Change	-148.02%	-183.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$28.24M	$1.204M
YoY Change
Cash From Financing Activities	-4.980M	9.398M
YoY Change	-39.91%	-44.94%
NET CHANGE
Cash From Operating Activities	690.0K	8.434M
Cash From Investing Activities	6.700M	-11.58M
Cash From Financing Activities	-4.980M	9.398M
Net Change In Cash	2.410M	6.251M
YoY Change	-106.28%	-48.48%
FREE CASH FLOW
Cash From Operating Activities	$690.0K	$8.434M
Capital Expenditures	$2.260M	$2.497M
Free Cash Flow	-$1.570M	$5.937M
YoY Change	-76.2%	-125.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001778129
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2023Q1	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	021-340690
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	TerrAscend Corp.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A6
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	77 City Centre Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 501 - East Tower
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Mississauga
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L5B 1M5
CY2023Q1	dei	City Area Code CityAreaCode	855
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	837-7295
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Bankruptcy Proceedings Reporting Current EntityBankruptcyProceedingsReportingCurrent	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	274653743
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32931000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26158000
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	606000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	605000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8993000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22443000
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	2026000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	3595000
CY2023Q1	us-gaap	Inventory Net InventoryNet	50810000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46335000
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	14266000
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	17349000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3627000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4937000
CY2023Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	525000
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	571000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	113784000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	121993000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	214035000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	215812000
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	740000
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	837000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29951000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29451000
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	243759000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239704000
CY2023Q1	us-gaap	Goodwill Goodwill	95713000
CY2022Q4	us-gaap	Goodwill Goodwill	90328000
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3594000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3462000
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	587792000
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	579594000
CY2023Q1	us-gaap	Assets Assets	701576000
CY2022Q4	us-gaap	Assets Assets	701587000
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	50784000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	44286000
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2740000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2935000
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	51397000
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	48335000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4434000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5184000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2314000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857000
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	535000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	521000
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	34737000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	23077000
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1663000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2599000
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	7468000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	9111000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	156072000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	137905000
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	146168000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	145852000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31836000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31545000
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6614000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6713000
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	267000
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	711000
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	34498000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	30700000
CY2023Q1	trssf	Financing Obligations Noncurrent FinancingObligationsNoncurrent	10979000
CY2022Q4	trssf	Financing Obligations Noncurrent FinancingObligationsNoncurrent	11198000
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15841000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15792000
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	246203000
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	242511000
CY2023Q1	us-gaap	Liabilities Liabilities	402275000
CY2022Q4	us-gaap	Liabilities Liabilities	380416000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	274653743
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	259624531
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	936404000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	934972000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1738000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2085000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-641517000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-618260000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	2676000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	299301000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	701576000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	701587000
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	69720000
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49060000
CY2023Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	322000
CY2022Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	475000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69398000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48585000
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	35498000
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	32961000
CY2023Q1	us-gaap	Gross Profit GrossProfit	33900000
CY2022Q1	us-gaap	Gross Profit GrossProfit	15624000
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27730000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21424000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2029000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2175000
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	335000
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	30094000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	23599000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3806000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7975000
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	119000
CY2023Q1	trssf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	438000
CY2022Q1	trssf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	5713000
CY2023Q1	trssf	Finance And Other Expenses FinanceAndOtherExpenses	10087000
CY2022Q1	trssf	Finance And Other Expenses FinanceAndOtherExpenses	6655000
CY2023Q1	trssf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	3000
CY2022Q1	trssf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	615000
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	31000
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-356000
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-699000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6514000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10007000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12664000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3743000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19178000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-13750000
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3591000
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2256000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-22769000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16006000
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	347000
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3607000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-23116000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-19613000
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-21364000
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14101000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	2186000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	351000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25302000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19964000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2186000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	351000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	267211093
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	211126932
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.07
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	267211093
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	211126932
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2023Q1	trssf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised	81000
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	743000
CY2023Q1	trssf	Stock Options And Warrants Issued During Period Value Legal Settlement StockOptionsAndWarrantsIssuedDuringPeriodValueLegalSettlement	593000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1713000
CY2023Q1	trssf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-1884000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-22769000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-347000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	299301000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	228954000
CY2022Q1	trssf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised	24702000
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	288044000
CY2022Q1	trssf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	22000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3356000
CY2022Q1	trssf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-227000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16006000
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3606000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	525239000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19178000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-13750000
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	797000
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	1073000
CY2023Q1	trssf	Accretion Expenses Net AccretionExpensesNet	-4763000
CY2022Q1	trssf	Accretion Expenses Net AccretionExpensesNet	1337000
CY2023Q1	trssf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	4771000
CY2022Q1	trssf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	4642000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	454000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	487000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1713000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3356000
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1446000
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1134000
CY2023Q1	trssf	Gain Lss On Warrants And Derivative GainLssOnWarrantsAndDerivative	438000
CY2022Q1	trssf	Gain Lss On Warrants And Derivative GainLssOnWarrantsAndDerivative	5713000
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-307000
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	119000
CY2023Q1	trssf	Loss On Derecognition Of Right Of Use Assets LossOnDerecognitionOfRightOfUseAssets	205000
CY2022Q1	trssf	Release Of Indemnification Asset ReleaseOfIndemnificationAsset	-25000
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	31000
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-356000
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-699000
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-773000
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2656000
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4969000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3755000
CY2023Q1	trssf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-1203000
CY2022Q1	trssf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-985000
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-97000
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	593000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	131000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-571000
CY2023Q1	trssf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	6882000
CY2022Q1	trssf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	-11151000
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-473000
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-271000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-14000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-437000
CY2022Q1	trssf	Increase Decrease In Contingent Consideration Payable IncreaseDecreaseInContingentConsiderationPayable	-324000
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	11773000
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4869000
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-195000
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	395000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	10454000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16783000
CY2023Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2020000
CY2022Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2064000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8434000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18847000
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2497000
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3812000
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14000
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	106000
CY2023Q1	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	111000
CY2022Q1	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	156000
CY2023Q1	trssf	Proceeds From Receipt Of Convertible Debenture Payment ProceedsFromReceiptOfConvertibleDebenturePayment	738000
CY2022Q1	trssf	Deposits For Property And Equipment DepositsForPropertyAndEquipment	6058000
CY2022Q1	trssf	Deposits For Business Acquisition DepositsForBusinessAcquisition	602000
CY2023Q1	trssf	Payments Made For Land Contracts PaymentsMadeForLandContracts	308000
CY2023Q1	trssf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	9611000
CY2022Q1	trssf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	-24716000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-11581000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	14294000
CY2022Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-381000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11581000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13913000
CY2023Q1	trssf	Transfer Of Employee Retention Credit TransferOfEmployeeRetentionCredit	12677000
CY2023Q1	trssf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	81000
CY2022Q1	trssf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	23925000
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1204000
CY2023Q1	trssf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	1884000
CY2022Q1	trssf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	227000
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6630000
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	157000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9513000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	17068000
CY2023Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-115000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9398000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17068000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6251000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12134000
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	523000
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3369000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26763000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79642000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33537000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88407000
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-551000
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2456000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	8271000
CY2022Q1	trssf	Payments For Lease Termination Fee PaymentsForLeaseTerminationFee	3300000
CY2023Q1	trssf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	750000
CY2022Q1	trssf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	294800000
CY2023Q1	trssf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	593000
CY2022Q1	trssf	Stock Issued During Period Value Liability Settlement StockIssuedDuringPeriodValueLiabilitySettlement	22000
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	555000
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	56000
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="notes" style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Na</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">ture of operations</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">TerrAscend Corp. (“TerrAscend” or the “Company”) was incorporated under the Ontario Business Corporations Act on </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">March 7, 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. TerrAscend provides cannabis products, brands, and services to the United States (“U.S.”) and Canadian cannabinoid markets where cannabis production or consumption has been legalized for therapeutic or adult use. TerrAscend operates a number of synergistic businesses, including Gage Growth ("Gage"), a cultivator, processor and retailer in Michigan; KISA Enterprises MI, LLC and KISA Holdings LLC (collectively "Pinnacle"); The Apothecarium (“The Apothecarium”), a cannabis dispensary with several retail locations in California, Pennsylvania and New Jersey; TerrAscend NJ, LLC ("TerrAscend NJ"), a cultivator, processor and retailer with operations in New Jersey; Ilera Healthcare (“Ilera”), Pennsylvania’s medical cannabis cultivator, processor and dispenser; HMS Health, LLC and HMS Processing, LLC (collectively “HMS”), a medical cannabis cultivator and processor based in Maryland; Valhalla Confections, a manufacturer of cannabis-infused edibles; and State Flower, a California-based cannabis producer operating a licensed cultivation facility in San Franci</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">sco. Notwithstanding various states in the U.S. which have implemented medical marijuana laws, or which have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">On January 27, 2023, the Company closed on its previously announced acquisition of Allegany Medical Marijuana Dispensary ("AMMD")</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">. Under the terms of the agreement, the Company acquired </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% equity interest in AMMD for total consideration of $</span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> in cash, in addition to entering into a long-term lease with the option to purchase the real estate. The Company now operates vertically integrated licensed operations in Maryland.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The Company has been listed on the Canadian Securities Exchange ("CSE") since May 3, 2017, having the ticker symbol "TER" and effective October 22, 2018, the Company began trading on OTCQX under the ticker symbol "TRSSF". The Company’s registered office is located at 77 City Centre Drive, Suite 501, Mississauga, Ontario, L5B 1M5.</span></p>
CY2023Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2017-03-07
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-641517000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19178000
CY2023Q1	trssf	Trade Receivables Gross TradeReceivablesGross	18394000
CY2022Q4	trssf	Trade Receivables Gross TradeReceivablesGross	14786000
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	235000
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	277000
CY2023Q1	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	1241000
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	17936000
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10878000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10556000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8993000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22443000
CY2022	us-gaap	Payments To Employees PaymentsToEmployees	14903000
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	12667000
CY2022Q4	trssf	Factoring Interests FactoringInterests	14903000
CY2023Q1	trssf	Employee Retension Credits Transfer Fee As Percentage Of Claim EmployeeRetensionCreditsTransferFeeAsPercentageOfClaim	0.15
CY2023Q1	trssf	Percentage Of Repay Of Funds Received Plus Interest Accrued PercentageOfRepayOfFundsReceivedPlusInterestAccrued	0.10
CY2023Q1	trssf	Trade Receivables Gross TradeReceivablesGross	18394000
CY2022Q4	trssf	Trade Receivables Gross TradeReceivablesGross	14786000
CY2023Q1	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10878000
CY2022Q4	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10556000
CY2023Q1	trssf	Trade Receivables Net TradeReceivablesNet	7516000
CY2022Q4	trssf	Trade Receivables Net TradeReceivablesNet	4230000
CY2023Q1	trssf	Trade Receivable Current TradeReceivableCurrent	6244000
CY2022Q4	trssf	Trade Receivable Current TradeReceivableCurrent	4045000
CY2023Q1	trssf	Trade Receivable3190 Days TradeReceivable3190Days	1009000
CY2022Q4	trssf	Trade Receivable3190 Days TradeReceivable3190Days	614000
CY2023Q1	trssf	Trade Receivable Over90 Days TradeReceivableOver90Days	11141000
CY2022Q4	trssf	Trade Receivable Over90 Days TradeReceivableOver90Days	10127000
CY2023Q1	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10878000
CY2022Q4	trssf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10556000
CY2023Q1	trssf	Trade Receivables Net TradeReceivablesNet	7516000
CY2022Q4	trssf	Trade Receivables Net TradeReceivablesNet	4230000
CY2023Q1	trssf	Number Of Customers Agreed To Payment Plan Over Ninety Days NumberOfCustomersAgreedToPaymentPlanOverNinetyDays	1
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	5184000
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	750000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	4434000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4434000
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1664000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1181000
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16500000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15280000
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	28724000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	26406000
CY2023Q1	trssf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	3922000
CY2022Q4	trssf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	3468000
CY2023Q1	us-gaap	Inventory Net InventoryNet	50810000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46335000
CY2023Q1	trssf	Facility Held For Sale FacilityHeldForSale	67300
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	240354000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	235496000
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26319000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19684000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	214035000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	215812000
CY2023Q1	trssf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2022	trssf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2023Q1	us-gaap	Depreciation Depreciation	3257000
CY2022Q1	us-gaap	Depreciation Depreciation	2191000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	188049000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27047000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	161002000
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	270806000
CY2023Q1	trssf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	27047000
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	243759000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	181522000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24575000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156947000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	82757000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	264279000
CY2022Q4	trssf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	24575000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	239704000
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1514000
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2451000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5798000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7739000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7473000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7458000
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7378000
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q4	us-gaap	Goodwill Goodwill	90328000
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5385000
CY2023Q1	us-gaap	Goodwill Goodwill	95713000
CY2022Q4	us-gaap	Loans Payable LoansPayable	194187000
CY2023Q1	us-gaap	Interest Expense Long Term Debt Increase Decrease InterestExpenseLongTermDebtIncreaseDecrease	7046000
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	3659000
CY2023Q1	trssf	Effects Of Movements In Foreign Exchange Loans Payable EffectsOfMovementsInForeignExchangeLoansPayable	-9000
CY2023Q1	us-gaap	Loans Payable LoansPayable	197565000
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	51397000
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	146168000
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2456000
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	8271000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y9M18D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1070
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1069
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0989
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0989
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	47613000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	105803000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	758000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2274000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	42446000
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	198894000
CY2023Q1	trssf	Number Of Finance Lease NumberOfFinanceLease	5
CY2022	trssf	Number Of Finance Lease NumberOfFinanceLease	3
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29951000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29451000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2314000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1857000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31836000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31545000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	34150000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	33402000
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6531000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	6673000
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	535000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	521000
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6614000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6713000
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	7149000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	7234000
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1254000
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1182000
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y4M24D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M9D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	320000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	630000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.75
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1254000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5053000
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	780000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3097000
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	222000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	220000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6913000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4089000.00
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	652000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	4741000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5434000.00
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2887000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Due Next Twelve Months OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	8321000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5414000.00
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	908000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	6322000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5137000.00
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	928000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	6065000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4635000.00
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	956000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	5591000
CY2023Q1	trssf	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	39547000.00
CY2023Q1	trssf	Finance Lease Liability Payments Due After Year Four FinanceLeaseLiabilityPaymentsDueAfterYearFour	3870000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Due After Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour	43417000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	64256000.00
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10201000.00
CY2023Q1	trssf	Operating And Finance Lease Liability Payments Due OperatingAndFinanceLeaseLiabilityPaymentsDue	74457000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	30106000
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3052000
CY2023Q1	trssf	Operating And Finance Lease Liability Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	33158000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	34150000
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	7149000
CY2023Q1	trssf	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	41299000
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	405134
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.19
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	468000
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	550000
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	445000
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	261000
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1724000
CY2023Q1	trssf	Financing Obligations Due In Remainder Of Fiscal Year FinancingObligationsDueInRemainderOfFiscalYear	1444000
CY2023Q1	trssf	Financing Obligations Due In Next Twelve Months FinancingObligationsDueInNextTwelveMonths	1940000
CY2023Q1	trssf	Financing Obligations Due In Second Year FinancingObligationsDueInSecondYear	1986000
CY2023Q1	trssf	Financing Obligations Due In Third Year FinancingObligationsDueInThirdYear	2032000
CY2023Q1	trssf	Financing Obligations Due In Fourth Year FinancingObligationsDueInFourthYear	2079000
CY2023Q1	trssf	Financing Obligations Due After Fourth Year FinancingObligationsDueAfterFourthYear	5680000
CY2023Q1	trssf	Financing Obligations Due FinancingObligationsDue	15161000
CY2023Q1	trssf	Financing Obligations Undiscounted Excess Amount FinancingObligationsUndiscountedExcessAmount	-3352000
CY2023Q1	trssf	Financing Obligations FinancingObligations	11809000
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1713000
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3356000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20111246
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	666665
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.14
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	497019
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.83
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	19172428
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M10D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.56
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	364000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12415653
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M8D
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.52
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	162000
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	6756775
CY2023Q1	trssf	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y1M28D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.65
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	202000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	551000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	61000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.8004
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8016
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7755
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7789
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0285
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0321
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0163
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0351
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000
CY2023Q1	trssf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2022	trssf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4263000
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2511000
CY2022Q1	trssf	Finance And Other Expenses FinanceAndOtherExpenses	6655000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	415640
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13050
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	110406
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	40606
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	264628
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13050
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5367000
CY2023Q1	trssf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-1884000
CY2022	trssf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-7550000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2186000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4557000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	2676000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2023Q1	trssf	Loan Interest Accretion LoanInterestAccretion	7875000
CY2022Q1	trssf	Loan Interest Accretion LoanInterestAccretion	6926000
CY2023Q1	trssf	Employee Retention Credits Transfer With Recourse EmployeeRetentionCreditsTransferWithRecourse	2235000
CY2023Q1	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	240000
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	240000
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.94
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.37
CY2023Q1	trssf	Office And General Expense OfficeAndGeneralExpense	4004000
CY2022Q1	trssf	Office And General Expense OfficeAndGeneralExpense	3310000
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	3373000
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	2720000
CY2023Q1	trssf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	1244000
CY2022Q1	trssf	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	1246000
CY2023Q1	trssf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	1244000
CY2022Q1	trssf	Facility And Maintenance Expense FacilityAndMaintenanceExpense	607000
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	13496000
CY2022Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	8798000
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1713000
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3356000
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2656000
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1387000
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27730000
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21424000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	271000
CY2023Q1	trssf	Finance And Other Expenses FinanceAndOtherExpenses	10087000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69398000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	48585000
CY2023Q1	trssf	Number Of Major Customers NumberOfMajorCustomers	0
CY2022Q1	trssf	Number Of Major Customers NumberOfMajorCustomers	0
CY2022Q1	trssf	Sales Returns SalesReturns	1040000
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	587792000
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	579594000
CY2023Q1	trssf	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	711000
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	438000
CY2023Q1	trssf	Effects Of Movements In Foreign Exchange EffectsOfMovementsInForeignExchange	-6000
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	267000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000950170-23-021207-index-headers.html	Edgar Link	pending
0000950170-23-021207-index.html	Edgar Link	pending
0000950170-23-021207.txt	Edgar Link	pending
0000950170-23-021207-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trssf-20230331.htm	Edgar Link	pending
trssf-20230331.xsd	Edgar Link	pending
trssf-ex31_1.htm	Edgar Link	pending
trssf-ex31_2.htm	Edgar Link	pending
trssf-ex32_1.htm	Edgar Link	pending
trssf-ex32_2.htm	Edgar Link	pending
trssf-20230331_cal.xml	Edgar Link	unprocessable
trssf-20230331_def.xml	Edgar Link	unprocessable
trssf-20230331_lab.xml	Edgar Link	unprocessable
trssf-20230331_pre.xml	Edgar Link	unprocessable
trssf-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSNDF
TerrAscend Corp. Stock $tsndf

2023 Q2 Form 10-Q Financial Statement

#000095017023021207 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF TerrAscend Corp. Stock $tsndf

2023 Q2 Form 10-Q Financial Statement

#000095017023021207 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF
TerrAscend Corp. Stock $tsndf